Company page
Rhythm Pharmaceuticals, Inc.
Rhythm Pharmaceuticals, Inc. is a public company traded under the ticker RYTM in the American market. The company has a market capitalization of approximately $6.64 billion. Rhythm focuses on developing innovative therapies for the treatment of rare genetic disorders of obesity.
- Ticker
- RYTM:NASDAQ
- Asset type
- Stock
- Market cap
- $6.64B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD